세계의 채혈기 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2027년)

Blood Collection Devices Market By Product Type (Blood Collection Tubes [Edta, Heparin, And Others]), By Method (Manual And Automatic), By End-User (Hosptials And Clinics, Diagnostic Labs, Blood Banks, And Others) by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to a surge in the prevalence of infectious diseases and the rising awareness on blood donations

The global blood collection devices market was valued at USD 6.23 billion in 2021, growing at a CAGR of 6.85% during the forecast period from 2022 to 2027 to reach USD 9.25 billion by 2027. The blood collection devices market is slated to witness prosperity owing to factors such as increase in diagnostic tests owing to the growing prevalence of infectious diseases such as COVID-19, malaria, and others, increasing awareness over health, rise in blood transfusion procedures, and the growing focus on improving the safety and usability of blood collection devices for end users are further expected to result in the appreciable revenue growth in the blood collection devices market during the forecast period (2022-2027).

Blood Collection Devices Market Dynamics:

Among the noteworthy drivers of the blood collection devices market, the rising prevalence of infectious diseases leading to a vast array of blood sample collection and testing turns out to be the major factor for accelerating the blood collection devices market. For instance, according to World Health Organization (WHO) 2022, globally there were around 37.7 million people suffering from human immunodeficiency virus (HIV) in the year 2020. One of the diagnostic test for HIV is Nucleic Acid Test (NAT), where blood is drawn from vein and tested for the presence of virus. The test also measures the viral load in a blood sample. Also, as per World Health Organization (WHO) 2022, worldwide there were around 241 million cases of malaria estimated in the year 2020. The blood sample is collected for conducting microscopic diagnosis, serology testing, molecular diagnosis, and drug resistance tests for the detection of malarial parasites in blood.

Further, increasing demand for routine health checkups owing to rising awareness on health is going to boost the market growth for blood collection devices. For example blood sample is collected for conducting general blood tests and organ function tests including liver function test, kidney function tests, and thyroid function tests among others that may indicate the presence of any medical condition. Routine health checkups along with helping in early diagnosis may also help in reducing the mortality rate and will allow to live a healthier life.

Another key factor responsible for the growth of the blood collection devices market is the continuous rise in blood donations. For instance, as per the latest data provided by the World Health Organization 2022, globally around 118.5 million blood donations are collected. This can be due to several awareness programs conducted by government and non-government organizations on how blood donation can save lives. For example every year on 14 June World Blood Donor Day is celebrated with several objectives in mind including increasing awareness regarding safe blood and blood products for transfusion, and increasing voluntary and unpaid blood donations among others. In the process of blood donation, various blood collection devices are utilized such as blood collection monitors or mixers, blood bag tube sealers, and blood transportation boxes among others, for effective drawing, transport, and storage of collected blood samples.

However, risk of blood sample contamination during transport and storage and lack of skilled phlebotomists may act as restraining factors to the blood collection devices market growth.

The blood collection devices market reported a short period of restraint in market growth due to the implementation of lockdown as necessary measures to prevent the spread of COVID-19 infection leading to suspension of routine diagnostic checkups. Also, during the initial phases owing to the lockdown the manufacturing and supply of blood collected devices was affected leading to further decline in the market. But later due to tremendous increase in the COVID-19 cases the demand for blood testing and plasma donation also increased leading to slight improvement in the blood collection devices market. Moreover with the resumption of activities including routine health checkups, test for other diseases, and others across industries including the healthcare sector, it has been uplifting for the blood collection devices market during the forecast period from 2022-2027.

Blood Collection Devices Market Segment Analysis:

Blood Collection Devices Market by Product Type (Blood Collection Tubes [EDTA, Heparin, and Others]), Method (Manual and Automatic), End-User (Hospitals and Clinics, Diagnostic Labs, Blood Banks, and Others) Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the method segment of the blood collection devices market, the automatic blood collection devices category is projected to register a significant growth in revenue in the blood collection devices market during the forecast period (2022-2027).

This can be ascribed to the advantages associated with the automated blood collection devices over traditional blood collection methods. Some of the advantages associated with automated blood collection system are that drawing of blood products became comparatively easier such as only the required volume of the blood will get collected instead of low or extra amount of blood and there is no need of insertion of needles multiple times as in case of manual blood collection system and thus, improving the donor experience. Further, there are less chance of errors in automated blood collection systems. Automated blood collection systems improve the efficiency and quality of blood collection process while maintaining the donor safety.

Also, automated blood collection systems can reduce the Total Turnaround Time and it also follows one-touch system where there is no need of additional handling of samples and thus minimizing the sample mix-up, contamination, spillage, and others. For example, TERUMO BCT, INC.'s automated blood collection system Trima Accel® Version 7 is the only device that can collect any transfusable component in any combination and also offers several features including simple device operation, minimization of manual documentation through electronic data capture, error reduction, improved traceability, quicker and high quality sample collection among others.

Therefore, considering the growing demand for this product type, numerous new products are being launched in the market. In March 2022, Terumo Blood and Cell Technologies, a medical device company received U.S. Food and Drug Administration (FDA) approval for its new plasma collection system named Rika Plasma Donation System (Rika) which is a next-generation automated technology with safety features to minimize operator errors and collects plasma in 35 minutes or less. Therefore, considering the advantages associated with automated blood collection system and their growing popularity among end users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global automated blood collection devices market during the forecast period.

North America is expected to dominate the overall Blood Collection Devices Market:

Among all the regions, North America is expected to lead in revenue generation in the global blood collection devices market. This can be ascribed to the presence of large patient pool associated with cancer and other diseases, increase in blood transfusion procedures, and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

One of the prominent factors supporting the growth of the North America blood collection devices market is the extensive use of blood collection devices by end users, majorly in the United States for sample collection in the diagnosis of multiple diseases. For instance, as per the Centers for Disease Control and Prevention (CDC) (2022), around 1,752,735 new cancer cases were reported in the year 2019 in the US. Blood testing is often conducted for the diagnosis of cancer among other methods.

Another factor contributing in the growth of blood collection devices is the continuous rise in the blood transfusion procedures. For instance, as per the Centers for Disease Control and Prevention 2020, there are around 13.2 million blood donors in the United States, resulting in a total of 17.2 million transfused blood product units per year. Blood transfusion is done in case of surgeries, and other medical conditions such as anemia, hemophilia, and others. The rise in the prevalence of blood cancer where patient may require blood transfusion for relieving symptoms and side effects in the US is another factor causing growth of blood collection devices market in the region. For instance, as per Globocan 2021 data, there were around 61,152 new cases of leukemia recorded in 2020. As per the same source around 73, 652 cases of Non-Hodgkin lymphoma and 8,107 new cases of Hodgkin lymphoma were recorded in 2020 in the US.

Therefore, along with the presence of large patient pool in the country, the increasing focus of manufacturers on launching new products in the market is expected to bolster the growth of the blood collection devices market in the United States during the forecast period.

Blood Collection Devices Market Key Players:

Some of the key market players operating in the blood collection devices market includes BD, Terumo Corporation, Haemonetics Corporation, Fresenius SE & Co. KGaA, Nipro Europe Group Companies, FL MEDICAL s.r.l., Greiner Bio-One International GmbH, Cardinal Health, SARSTEDT AG & Co. KG, Thermo Fisher Scientific Inc., ICU Medical, Grifols, S.A, CML Biotech, INTERNATIONAL SCIENTIFIC SUPPLIES LTD, Demophorius Healthcare LTD, AB MEDICAL Co., Ltd., Trajan Scientific and Medical, Macopharma, VOGT MEDICAL, Ljungberg & Kogel AB, and others.

Recent Developmental Activities in Blood Collection Devices Market:

• In February 2022, Abacus dx announced the launch of RNA Complete BCT™ which is a newest addition to Streck's trusted blood collection tube portfolio. The tube allows for convenient sample collection, transport, and storage.
• In July 2021, Becton, Dickinson and Company (BD) received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its BD Vacutainer plus Citrate Plasma Tubes, which are sodium citrate blood specimen collection tubes used to collect, transport, and store blood samples for coagulation testing.
• In August 2019, Drawbridge Health received U.S. Food and Drug Administration (FDA) approval for its OneDraw™ A1C Test System, which comprises of OneDraw Blood Collection Device and the OneDraw A1C Test. The device enables blood to be drawn quickly, comfortably, and conveniently by a health care professional

Key Takeaways from the Blood Collection Devices Market Report Study

• Market size analysis for current blood collection devices market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the blood collection devices market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years
• Key companies dominating the global blood collection devices market.
• Various opportunities available for the other competitor in the blood collection devices market space.
• What are the top performing segments in 2021? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current blood collection devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for blood collection devices market growth in the coming future?

Target Audience who can be benefited from this Blood Collection Devices Market Report Study

• Blood collection devices products providers
• Research organizations and consulting companies
• Blood collection devices -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in blood collection devices
• Various end users who want to know more about the blood collection devices market and latest technological developments in the blood collection devices market.

Frequently Asked Questions for Blood Collection Devices Market:

1. What are blood collection devices?

• Blood collection devices are the medical devices that are employed in the safe and effective collection, transport, and storage of blood samples to be used later for diagnostic and treatment purposes.

2. What is the market for the global blood collection devices?

• The global blood collection devices market was valued at USD 6.23 billion in 2021, growing at a CAGR of 6.85% during the forecast period from 2022 to 2027 to reach USD 9.25 billion by 2027.

3. What are the drivers for the global blood collection devices market?

• The blood collection devices market is slated to witness prosperity owing to factors such as increase in diagnostic tests owing to the growing prevalence of infectious diseases such as COVID-19, and HIV among others, increasing awareness on blood donation, rising demand for routine health check-ups and the growing focus on improving the safety and usability of blood collection devices for end users are further expected to result in the appreciable revenue growth in the blood collection devices market during the forecast period (2022-2027).

4. Who are the key players operating in the global blood collection device market?

• Some of the key market players operating in the blood collection devices market includes BD, Terumo Corporation, Haemonetics Corporation, Fresenius SE & Co. KGaA, Nipro Europe Group Companies, FL MEDICAL s.r.l., Greiner Bio-One International GmbH, Cardinal Health, SARSTEDT AG & Co. KG, Thermo Fisher Scientific Inc., ICU Medical, Grifols, S.A, CML Biotech, INTERNATIONAL SCIENTIFIC SUPPLIES LTD, Demophorius Healthcare LTD, AB MEDICAL Co., Ltd., Trajan Scientific and Medical, Macopharma, VOGT MEDICAL, Ljungberg & Kogel AB, and others.

5. Which region has the highest share in the blood collection devices market?

• North America is expected to dominate the overall blood collection devices market during the forecast period, 2022 to 2027. This can be ascribed to the presence of large patient pool associated with multiple diseases such as cancer, anaemia and others, rise in voluntary blood donation, increase in blood transfusion procedures in the region, high tech medical facilities, government initiatives, and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1.Blood Collection Devices Market Report Introduction

2.Blood Collection Devices Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Blood Collection Devices Market Key Factors Analysis

• 4.1. Blood Collection Devices Market Drivers
  • 4.1.1. Increase in number of diagnostic tests due to increasing prevalence of infectious diseases
  • 4.1.2. Increasing demand for routine health checkups
  • 4.1.3. Rise in blood transfusion procedures
  • 4.1.4. Increasing awareness about blood donation
• 4.2. Blood Collection Devices Market Restraints and Challenges
  • 4.2.1. Risk of blood sample contamination during transport and storage
  • 4.2.2. Lack of skilled phlebotomists
• 4.3. Blood Collection Devices Market Opportunities
  • 4.3.1. Improving product safety such as easy and contamination free transport and storage of blood samples
  • 4.3.2. Increasing affordability and availability of automated blood collection system

5. Blood Collection Devices Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Blood Collection Devices Market

7. Blood Collection Devices Market Layout

• 7.1. By Product Type
  • 7.1.1. Blood collection tubes/Vacutainer
    • 7.1.1.1. EDTA
    • 7.1.1.2. Heparin
    • 7.1.1.3. Others
  • 7.1.2. Needles and Syringes
  • 7.1.3. Blood collection bags
  • 7.1.4. Others
• 7.2. By Method Type
  • 7.2.1. Manual
  • 7.2.2. Automatic
• 7.3. By End-user
  • 7.3.1. Hospitals and Clinics
  • 7.3.2. Diagnostic Labs
  • 7.3.3. Blood Banks
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.1.2. Canada Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.1.3. Mexico Blood Collection Devices Market in USD million (2019-2027)
  • 7.4.2. Europe
    • 7.4.2.1. France Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.2. Germany Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.3. United Kingdom Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.4. Italy Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.5. Spain Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.6. Russia Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.2.7. Rest of Europe Blood Collection Devices Market in USD million (2019-2027)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.3.2. Japan Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.3.3. India Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.3.4. Australia Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.3.5. South Korea Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.3.6. Rest of Asia Pacific Blood Collection Devices Market in USD million (2019-2027)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.4.2. Africa Blood Collection Devices Market in USD million (2019-2027)
    • 7.4.4.3. South America Blood Collection Devices Market in USD million (2019-2027)

8. Blood Collection Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Blood Collection Devices Market Company and Product Profiles

• 9.1. BD
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Terumo Corporation
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Haemonetics Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Fresenius SE & Co. KGaA
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Nipro Europe Group Companies
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. FL MEDICAL s.r.l.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Greiner Bio-One International GmbH
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Cardinal Health
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. SARSTEDT AG & Co. KG
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Thermo Fisher Scientific Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. ICU Medical
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Grifols, S.A
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. CML Biotech
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. INTERNATIONAL SCIENTIFIC SUPPLIES LTD
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. Demophorius Healthcare LTD
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. AB MEDICAL Co., Ltd.
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Trajan Scientific and Medical
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Macopharma
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19. VOGT MEDICAL
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20. Ljungberg & Kogel AB
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us